Compugen (CGEN) News Today $1.40 -0.07 (-4.76%) Closing price 04:00 PM EasternExtended Trading$1.42 +0.02 (+1.43%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGEN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Compugen (CGEN) Gets a Buy from Leerink PartnersAugust 28 at 8:13 AM | theglobeandmail.comCompugen Reports Q2 2025 Results and Advances in Immuno-Oncology TrialsAugust 28 at 8:13 AM | theglobeandmail.comCompugen to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceAugust 28 at 7:00 AM | prnewswire.comConnor Clark & Lunn Investment Management Ltd. Trims Position in Compugen Ltd. $CGENAugust 23, 2025 | marketbeat.comLeerink Partnrs Predicts Increased Earnings for CompugenAugust 12, 2025 | marketbeat.comCompugen (NASDAQ:CGEN) Downgraded by Wall Street Zen to SellAugust 10, 2025 | marketbeat.comNeed To Know: Analysts Just Made A Substantial Cut To Their Compugen Ltd. (NASDAQ:CGEN) EstimatesAugust 9, 2025 | finance.yahoo.comCompugen: Potential Best-In-Class Anti-PVRIG COM701 Shifts To Targeting PSOC PatientsAugust 8, 2025 | seekingalpha.comCompugen Ltd. (CGEN) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comCompugen Reports Second Quarter 2025 ResultsAugust 6, 2025 | prnewswire.comCompugen (CGEN) Expected to Announce Quarterly Earnings on WednesdayJuly 30, 2025 | marketbeat.comCompugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resistant Ovarian Cancer at ESMO 2025July 28, 2025 | prnewswire.comARK Investment Management LLC Makes New Investment in Compugen Ltd. (NASDAQ:CGEN)July 27, 2025 | marketbeat.comCompugen to Release Second Quarter 2025 Results on Wednesday, August 6, 2025July 23, 2025 | prnewswire.comCompugen Announces First Patient Dosed in COM701 Global Platform Trial in Platinum Sensitive Ovarian CancerJuly 21, 2025 | prnewswire.comCompugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific ConferencesJune 12, 2025 | prnewswire.comMillennium Management LLC Acquires 156,959 Shares of Compugen Ltd. (NASDAQ:CGEN)June 9, 2025 | marketbeat.comNorthern Trust Corp Raises Stock Position in Compugen Ltd. (NASDAQ:CGEN)May 29, 2025 | marketbeat.comThese Analysts Just Made An Incredible Downgrade To Their Compugen Ltd. (NASDAQ:CGEN) EPS ForecastsMay 25, 2025 | uk.finance.yahoo.comAnalysts Offer Predictions for Compugen FY2025 EarningsMay 24, 2025 | marketbeat.comQ2 Earnings Estimate for Compugen Issued By Leerink PartnrsMay 23, 2025 | marketbeat.comCompugen Ltd. (CGEN) Q1 2025 Earnings Call TranscriptMay 21, 2025 | seekingalpha.comCompugen First Quarter 2025 Earnings: Misses ExpectationsMay 20, 2025 | uk.finance.yahoo.comCompugen Ltd. (NASDAQ:CGEN) Q1 2025 Earnings Call TranscriptMay 20, 2025 | insidermonkey.comCompugen Ltd. (NASDAQ:CGEN) Q1 2025 Earnings Call TranscriptMay 20, 2025 | msn.comCompugen’s Q1 2025: Clinical Progress and Financial StabilityMay 19, 2025 | tipranks.comCompugen Ltd.: Compugen Reports First Quarter 2025 ResultsMay 19, 2025 | finanznachrichten.deCompugen Reports Q1 2025 Results and Strategic DevelopmentsMay 19, 2025 | tipranks.comCompugen Reports First Quarter 2025 ResultsMay 19, 2025 | prnewswire.comUncovering Potential: Compugen's Earnings PreviewMay 16, 2025 | benzinga.comCompugen Q1 2025 Earnings PreviewMay 16, 2025 | msn.comCompugen announces executive leadership changesMay 15, 2025 | uk.investing.comCompugen Announces Leadership Transitions Effective September 2025May 13, 2025 | prnewswire.comCompugen (CGEN) Projected to Post Quarterly Earnings on MondayMay 13, 2025 | marketbeat.comCompugen to Release First Quarter 2025 Results on Monday, May 19, 2025May 5, 2025 | prnewswire.comCompugen to Participate in Multiple Virtual Investor Conferences in April 2025March 26, 2025 | prnewswire.comCompugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to AnalystsMarch 23, 2025 | insidermonkey.comCompugen (NASDAQ:CGEN) Cut to "Hold" at StockNews.comMarch 6, 2025 | marketbeat.comCalculating The Intrinsic Value Of Compugen Ltd. (NASDAQ:CGEN)March 6, 2025 | uk.finance.yahoo.comCompugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | insidermonkey.comCompugen reports Q4 EPS (7c) vs. 11c last yearMarch 4, 2025 | markets.businessinsider.comCompugen Ltd. (CGEN) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comCompugen (NASDAQ:CGEN) Issues Quarterly Earnings Results, Misses Expectations By $0.14 EPSMarch 4, 2025 | marketbeat.comCompugen Reports Fourth Quarter and Full Year 2024 ResultsMarch 4, 2025 | prnewswire.comCompugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare ConferenceMarch 3, 2025 | prnewswire.comCompugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing TechnologyFebruary 26, 2025 | prnewswire.comCompugen (CGEN) Projected to Post Quarterly Earnings on TuesdayFebruary 25, 2025 | marketbeat.comCompugen Ltd. Sets Date for Q4 2024 Financial Results AnnouncementFebruary 18, 2025 | tipranks.comCompugen: Immuno-Oncology Innovator Poised For A ComebackFebruary 18, 2025 | seekingalpha.comCompugen to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, March 4, 2025February 18, 2025 | prnewswire.com Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CGEN Media Mentions By Week CGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEN News Sentiment▼0.711.03▲Average Medical News Sentiment CGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEN Articles This Week▼51▲CGEN Articles Average Week Get the Latest News and Ratings for CGEN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Compugen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Alumis News Arcturus Therapeutics News Evolus News Bicycle Therapeutics News Tectonic Therapeutic News Nanobiotix News Cullinan Therapeutics News Prime Medicine News Prothena News Autolus Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGEN) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access